The International Diabetic Neuropathy Consortium (IDNC) funded by the Novo Nordisk Foundation will over a 6-year period study the mechanisms leading to painful and non-painful diabetic neuropathy. The project is a joint venture between key researchers at Aarhus University, the University of Southern Denmark, the University of Oxford, UK, and the University of Michigan, Ann Arbor, USA.
2015.05.21 |
Date | Fri 22 May |
Time | 14:00 — 16:00 |
Location | DNC Auditorium, AUH, building 10G, Nørrebrogade 44, Aarhus C. |
Official opening
Friday 22 May 2015 at 14.00-16.00
at the Danish Neuroscience Center (DNC), Aarhus University Hospital, Nørrebrogade 44, Building 10G, 8000 Aarhus C
Sign up for the event by emailing:
helleade@rm.dk
ALL ARE WELCOME
Download program for the opening here ...
PROGRAM:
PROGRAMME (Moderator: Associate Professor Nanna Brix Finnerup)
14.00 Opening of the IDNC Representative from the Novo Nordisk Foundation
14.05 IDNC and Aarhus University Allan Flyvbjerg, Dean, Health, Aarhus University
14.15 IDNC and Aarhus University Hospital
Kirsten Wisborg, Center Director, Head-Heart Center, Aarhus University Hospital
14.20 Research programme for IDNC
Troels Staehelin Jensen, Professor, Danish Pain Research Center, Aarhus University
14.30 Diabetic neuropathy: A neglected complication of diabetes
Eva L. Feldman, DeJong Professor of Neurology, Director, Program for Neurology Research & Discovery, Department of Neurology, University of Michigan, USA
14.40 Painful and non-painful diabetic neuropathy
David Bennett, Professor of Neurology, University of Oxford, UK
14.50 Capillary dysfunction: A hypothetical mechanism for diabetic neuropathy
Leif Østergaard, Professor, Center of Functionally Integrative Neuroscience, Aarhus University
15.00 Reception
We do look forward to seeing you at the official opening of the IDNC.
On behalf of the Steering Committee,
Troels Staehelin Jensen
Director of the IDNC, Aarhus University